Integrating Circulating Tumor Cell Data with Imaging and Serum Prostate-Specific Antigen Measurement for Metastatic Prostate Cancer Therapy Management

Publisher： Karger

E-ISSN： 1662-6575|7|1|217-221

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.7, Iss.1, 2014-03, pp. : 217-221

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Circulating Tumor Cell Data: Integration with Imaging and Serum Tumor Markers for Metastatic Breast Cancer Patient Management

By  

Case Reports in Oncology, Vol. 7, Iss. 1, 2014-03 ,pp. : 175-181

Karger

Access to resources Recommend Favorite

Metastatic Prostate Cancer in an Asymptomatic Patient with an Initial Prostate-Specific Antigen (PSA) Serum Concentration of 21,380 ng/ml

By  

Oncology Research and Treatment, Vol. 33, Iss. 3, 2010-02 ,pp. : 110-112

Karger

Access to resources Recommend Favorite

Prognostic Significance of Changes in Short-Term Prostate Volume and Serum Prostate-Specific Antigen after Androgen Withdrawal in Men with Metastatic Prostate Cancer

By  

Urologia Internationalis, Vol. 70, Iss. 3, 2003-04 ,pp. : 195-199

Karger

Access to resources Recommend Favorite

Predictors of Delayed Therapy after Expectant Management for Localized Prostate Cancer in the Era of Prostate-Specific Antigen

By  

Oncology, Vol. 67, Iss. 3-4, 2004-11 ,pp. : 194-202

Karger

Access to resources Recommend Favorite

Systemic Inflammatory Response, Prostate-Specific Antigen and Survival in Patients with Metastatic Prostate Cancer

By  

Urologia Internationalis, Vol. 77, Iss. 2, 2006-08 ,pp. : 127-129

Karger

Access to resources Recommend Favorite